[{"address1": "1901 West 47th Place", "city": "Kansas City", "state": "KS", "zip": "66205", "country": "United States", "phone": "913 942 2300", "website": "https://www.cingulate.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company's stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults. It also focuses on developing CTx-2103 that is in a formulation stage for the treatment of anxiety. The company was founded in 2012 and is headquartered in Kansas City, Kansas.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Dr. Shane J. Schaffer Pharm.D.", "age": 48, "title": "CEO & Chairman of the Board", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 491961, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Laurie A. Myers M.B.A., Ph.D.", "age": 66, "title": "Executive VP & COO", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 415167, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew N. Brams M.D.", "age": 59, "title": "Executive VP & Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 244792, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer L. Callahan CPA", "age": 52, "title": "Senior VP, CFO & Secretary", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raul R. Silva M.D.", "age": 65, "title": "Executive VP & Chief Science Officer", "yearBorn": 1958, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Thomas  Dalton", "title": "Vice President of Investor & Public Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 6.43, "open": 6.63, "dayLow": 6.01, "dayHigh": 9.6899, "regularMarketPreviousClose": 6.43, "regularMarketOpen": 6.63, "regularMarketDayLow": 6.01, "regularMarketDayHigh": 9.6899, "beta": -1.077, "forwardPE": -0.5267023, "volume": 5248724, "regularMarketVolume": 5248724, "averageVolume": 3852097, "averageVolume10days": 3311670, "averageDailyVolume10Day": 3311670, "bid": 7.78, "ask": 9.36, "bidSize": 400, "askSize": 200, "marketCap": 13645124, "fiftyTwoWeekLow": 1.8, "fiftyTwoWeekHigh": 187.2, "fiftyDayAverage": 5.82008, "twoHundredDayAverage": 23.33756, "currency": "USD", "enterpriseValue": 7449002, "floatShares": 945506, "sharesOutstanding": 1729420, "sharesShort": 51592, "sharesShortPriorMonth": 16587, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0543, "heldPercentInsiders": 0.11152001, "heldPercentInstitutions": 0.08442, "shortRatio": 0.01, "shortPercentOfFloat": 0.0612, "impliedSharesOutstanding": 1729420, "bookValue": 3.95, "priceToBook": 1.9974684, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -19095904, "trailingEps": -326.4, "forwardEps": -14.98, "lastSplitFactor": "1:12", "lastSplitDate": 1723161600, "enterpriseToEbitda": -0.413, "52WeekChange": -0.94926697, "SandP52WeekChange": 0.2560848, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "CING", "underlyingSymbol": "CING", "shortName": "Cingulate Inc.", "longName": "Cingulate Inc.", "firstTradeDateEpochUtc": 1638973800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "bf898f9d-c1c1-3f31-9c96-a5b2c0f73dcd", "messageBoardId": "finmb_1674914781", "gmtOffSetMilliseconds": -14400000, "currentPrice": 7.89, "targetHighPrice": 240.0, "targetLowPrice": 70.0, "targetMeanPrice": 135.33, "targetMedianPrice": 96.0, "recommendationMean": 2.5, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 380928, "totalCashPerShare": 0.401, "ebitda": -18046852, "totalDebt": 330438, "quickRatio": 0.997, "currentRatio": 1.231, "debtToEquity": 10.715, "returnOnAssets": -2.25765, "freeCashflow": -12054312, "operatingCashflow": -17342736, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-01"}]